Back
Karuna Therapeutics Stock Price Chart

Early Profit-Advantage on 40-cent Stock as Uranium Bulls Take Over
More Here...
Buy
60
KRTX
Karuna Therapeutics
Last Price:
188.34
Seasonality Move:
1.93%
7 Day Trial
ALL ACCESS PASS
$
7

#1 Low-Priced Lithium Stock as Global EV Sales Accelerate
Find out more here.- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KRTX is experiencing selling pressure, which indicates risk of future bearish movement.
Karuna Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 183.55 | Buy |
20-day SMA: | 177.5 | Buy |
50-day SMA: | 172.89 | Buy |
200-day SMA: | 193.24 | Sell |
8-day EMA: | 184.39 | Buy |
20-day EMA: | 179.15 | Buy |
50-day EMA: | 177.31 | Buy |
200-day EMA: | 187.3 | Sell |
Karuna Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 4.17 | Buy |
Relative Strength Index (14 RSI): | 56.98 | Buy |
Chaikin Money Flow: | -72786 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (166.84 - 183.58) | Buy |
Bollinger Bands (100): | (167.93 - 194.19) | Buy |
Karuna Therapeutics Technical Analysis
Nov 14 | Nov 15 | Nov 16 | Nov 17 | Nov 20 | Nov 21 | Nov 22 | Nov 24 | Nov 27 | Nov 28 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
14 | 15 | 16 | 17 | 20 | 21 | 22 | 24 | 27 | 28 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Karuna Therapeutics Stock
Is Karuna Therapeutics Stock a Buy?
- Karuna Therapeutics share price is 185.35 while KRTX 8-day simple moving average is 183.55, which is a Buy signal.
- The stock price of KRTX is 185.35 while Karuna Therapeutics 20-day SMA is 177.50, which makes it a Buy.
- Karuna Therapeutics 50-day simple moving average is 172.89 while KRTX share price is 185.35, making it a Buy technically.
- KRTX stock price is 185.35 and Karuna Therapeutics 200-day simple moving average is 193.24, creating a Sell signal.
KRTX Technical Analysis vs Fundamental Analysis
Buy
60
Karuna Therapeutics (KRTX)
is a Buy
Is Karuna Therapeutics a Buy or a Sell?
-
Karuna Therapeutics stock is rated a Buy
The current Karuna Therapeutics [KRTX] share price is $185.35. The Score for KRTX is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
Karuna Therapeutics Stock Info
Market Cap:
6.99B
Price in USD:
185.35
Share Volume:
106.14K
Karuna Therapeutics 52-Week Range
52-Week High:
245.00
52-Week Low:
158.38
Buy
60
Karuna Therapeutics (KRTX)
is a Buy
Karuna Therapeutics Share Price Forecast
-
What is the Karuna Therapeutics stock price today?
The Karuna Therapeutics stock price is 185.35 USD today. -
Will KRTX stock go up or go down?
Karuna Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Karuna Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Karuna Therapeutics is not overvalued.
Is Karuna Therapeutics Stock a Buy?
- Karuna Therapeutics share price is 185.35 while KRTX 8-day exponential moving average is 184.39, which is a Buy signal.
- The stock price of KRTX is 185.35 while Karuna Therapeutics 20-day EMA is 179.15, which makes it a Buy.
- Karuna Therapeutics 50-day exponential moving average is 177.31 while KRTX share price is 185.35, making it a Buy technically.
- KRTX stock price is 185.35 and Karuna Therapeutics 200-day simple moving average is 187.30, creating a Sell signal.
Fundamental Analysis of Karuna Therapeutics
Is Karuna Therapeutics a good investment?
- Analysts estimate an earnings decrease this quarter of $0.41 per share, a decrease next quarter of $0.00 per share, a decrease this year of $2.18 per share, and an increase next year of $0.14 per share.
Technical Analysis of Karuna Therapeutics
Should I short Karuna Therapeutics stock?
- KRTX Moving Average Covergence Divergence (MACD) indicator is 4.17, suggesting Karuna Therapeutics is a Buy
- Karuna Therapeutics Relative Strength Index (RSI) is 56.98, which suggest Karuna Therapeutics is overbought
- The Bollinger Bands (25) for Karuna Therapeutics is (166.84 - 183.58), which suggest Karuna Therapeutics is a Buy
- The Bollinger Bands (100) for Karuna Therapeutics is (167.93 - 194.19), which suggest Karuna Therapeutics is a Buy
* Karuna Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.